Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 29 04:00PM ET
1.14
Dollar change
+0.03
Percentage change
2.70
%
IndexRUT P/E- EPS (ttm)-0.46 Insider Own25.70% Shs Outstand70.69M Perf Week7.55%
Market Cap83.14M Forward P/E- EPS next Y-0.61 Insider Trans0.00% Shs Float52.76M Perf Month-0.87%
Income-32.50M PEG- EPS next Q-0.17 Inst Own51.13% Short Float1.43% Perf Quarter0.88%
Sales0.63M P/S131.96 EPS this Y36.45% Inst Trans1.01% Short Ratio4.48 Perf Half Y-62.75%
Book/sh1.07 P/B1.06 EPS next Y-29.43% ROA-28.55% Short Interest0.76M Perf Year-62.62%
Cash/sh0.86 P/C1.33 EPS next 5Y- ROE-36.60% 52W Range0.68 - 4.10 Perf YTD-64.60%
Dividend Est.- P/FCF- EPS past 5Y18.87% ROI-35.71% 52W High-72.20% Beta0.29
Dividend TTM- Quick Ratio5.66 Sales past 5Y275.67% Gross Margin-35.28% 52W Low67.65% ATR (14)0.08
Dividend Ex-Date- Current Ratio5.66 EPS Y/Y TTM33.24% Oper. Margin-10980.45% RSI (14)50.25 Volatility3.84% 7.79%
Employees40 Debt/Eq0.21 Sales Y/Y TTM113.07% Profit Margin-5146.14% Recom1.44 Target Price3.38
Option/ShortYes / Yes LT Debt/Eq0.19 EPS Q/Q-23.85% Payout- Rel Volume0.76 Prev Close1.11
Sales Surprise63.98% EPS Surprise3.15% Sales Q/Q58.76% EarningsNov 12 BMO Avg Volume168.95K Price1.14
SMA20-1.34% SMA50-1.18% SMA200-41.30% Trades Volume129,111 Change2.70%
Date Action Analyst Rating Change Price Target Change
Jun-18-24Downgrade Oppenheimer Outperform → Perform
Apr-30-24Initiated B. Riley Securities Buy $9
Apr-29-24Initiated H.C. Wainwright Buy $9
Apr-05-24Initiated Wedbush Outperform $8
Dec-21-23Initiated BTIG Research Buy $11
Oct-13-23Initiated Oppenheimer Outperform $8
Apr-20-21Downgrade Cantor Fitzgerald Buy → Neutral $4
Mar-03-21Downgrade RBC Capital Mkts Outperform → Sector Perform $5
Dec-02-20Downgrade JMP Securities Mkt Outperform → Mkt Perform
Dec-02-20Downgrade Citigroup Buy → Neutral $10 → $4
Nov-12-24 09:30AM
08:00AM
Oct-31-24 08:00AM
Sep-26-24 08:00AM
Sep-20-24 04:00AM
08:00AM Loading…
Sep-11-24 08:00AM
Sep-04-24 08:00AM
Aug-20-24 12:00PM
Aug-13-24 09:10AM
08:00AM
07:00AM
Aug-08-24 08:00AM
Jul-30-24 08:00AM
Jul-23-24 08:00AM
Jul-22-24 07:00AM
10:45AM Loading…
Jul-15-24 10:45AM
09:35AM
Jul-10-24 08:00AM
Jul-01-24 08:00AM
Jun-18-24 09:51AM
Jun-17-24 01:45PM
01:28PM
01:03PM
12:38PM
08:07AM
06:55AM
May-28-24 01:09PM
May-20-24 06:00AM
May-14-24 01:54PM
09:10AM
08:00AM Loading…
08:00AM
May-13-24 07:00AM
Apr-30-24 07:23AM
Apr-29-24 07:18AM
Apr-26-24 10:00AM
Apr-04-24 08:00AM
Mar-17-24 05:19PM
Mar-08-24 08:00AM
Feb-28-24 08:00AM
Feb-06-24 08:00AM
Dec-01-23 07:30AM
Nov-09-23 12:00PM
08:48AM
Nov-05-23 07:15PM
Nov-03-23 08:00AM
Oct-19-23 10:44AM
Oct-18-23 08:00AM
Oct-10-23 08:00AM
Sep-29-23 03:16PM
Sep-26-23 07:30AM
Sep-20-23 07:30AM
Aug-30-23 08:00AM
Aug-15-23 09:38PM
Aug-04-23 09:15AM
08:00AM
Aug-01-23 08:00AM
Jul-31-23 09:29PM
Jul-02-23 10:00AM
Jun-28-23 08:00AM
Jun-26-23 08:00AM
May-22-23 06:43AM
May-05-23 08:45AM
07:30AM
May-01-23 06:00AM
Apr-27-23 02:30PM
Apr-12-23 12:00PM
Apr-11-23 06:51AM
Apr-10-23 08:00AM
Mar-15-23 06:21AM
Mar-13-23 08:00AM
Mar-09-23 08:00AM
Mar-08-23 08:00AM
Feb-28-23 08:00AM
Feb-08-23 08:00AM
Jan-22-23 07:37AM
Jan-05-23 08:00AM
Dec-02-22 10:00AM
Nov-17-22 07:23AM
Nov-08-22 08:00AM
Oct-18-22 08:57AM
Sep-27-22 08:00AM
Sep-26-22 09:21AM
Sep-07-22 08:00AM
Aug-14-22 10:40AM
Aug-09-22 08:00AM
Jun-10-22 07:41AM
Jun-06-22 08:00AM
May-11-22 06:55AM
May-10-22 08:00AM
Apr-26-22 07:17AM
Apr-08-22 08:00AM
Mar-15-22 08:00AM
Mar-07-22 01:06PM
Mar-04-22 08:00AM
Feb-28-22 01:51PM
Feb-08-22 08:00AM
Jan-04-22 08:01AM
Jan-03-22 07:25AM
06:30AM
Nov-10-21 08:30AM
Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LEVIN JEREMY MCEOMar 18 '24Buy2.7618,24850,3643,616,715Mar 20 05:22 PM